Adial Pharmaceuticals, Inc. (ADIL) vs Lisata Therapeutics, Inc. (LSTA)

A side-by-side comparison of Adial Pharmaceuticals, Inc. and Lisata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADIL vs LSTA

growth of $100 · dividends reinvested · last 8y
ADIL -99.8% (-54.9%/yr)LSTA -98.5% (-40.8%/yr)LSTA compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$0$2
ADIL LSTA

ADIL vs LSTA: by the numbers

  • •ADIL is the larger company ($11M vs $11M market cap).
  • •Both run net losses; ADIL's is the smaller (0.00% vs -14621.00% net margin).

Metrics side by side

Valuation

MetricADILLSTA
P/S ratioN/A106.54
P/B ratioN/A1.29

Profitability

MetricADILLSTA
Gross margin0.00%14.12%
Operating margin0.00%-10711.18%
Net margin0.00%-14621.00%
ROE-37052.06%-177.35%
ROIC-240.64%-204.32%

Growth (annualized)

MetricADILLSTA
Total return CAGR (5Y)-71.86%-40.75%

Frequently asked

How have ADIL and LSTA total returns compared?
Over the past 5 years, ADIL delivered -71.86% and LSTA delivered -40.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.